174 related articles for article (PubMed ID: 32473292)
21. Development of physiologically-based toxicokinetic-toxicodynamic (PBTK-TD) model for 4-nonylphenol (4-NP) reflecting physiological changes according to age in males: Application as a new risk assessment tool with a focus on toxicodynamics.
Jeong SH; Jang JH; Lee YB
Environ Pollut; 2022 Nov; 312():120041. PubMed ID: 36030954
[TBL] [Abstract][Full Text] [Related]
22. Toxicokinetic models and related tools in environmental risk assessment of chemicals.
Grech A; Brochot C; Dorne JL; Quignot N; Bois FY; Beaudouin R
Sci Total Environ; 2017 Feb; 578():1-15. PubMed ID: 27842969
[TBL] [Abstract][Full Text] [Related]
23. Application of physiologically-based toxicokinetic modelling in oral-to-dermal extrapolation of threshold doses of cosmetic ingredients.
Gajewska M; Worth A; Urani C; Briesen H; Schramm KW
Toxicol Lett; 2014 Jun; 227(3):189-202. PubMed ID: 24731971
[TBL] [Abstract][Full Text] [Related]
24. A Petri Net Approach to Physiologically Based Toxicokinetic Modeling.
Edhlund I; Lee C
Environ Toxicol Chem; 2019 May; 38(5):978-987. PubMed ID: 30756430
[TBL] [Abstract][Full Text] [Related]
25. In vitro-to-in vivo extrapolation (IVIVE) by PBTK modeling for animal-free risk assessment approaches of potential endocrine-disrupting compounds.
Fabian E; Gomes C; Birk B; Williford T; Hernandez TR; Haase C; Zbranek R; van Ravenzwaay B; Landsiedel R
Arch Toxicol; 2019 Feb; 93(2):401-416. PubMed ID: 30552464
[TBL] [Abstract][Full Text] [Related]
26. Using the concordance of in vitro and in vivo data to evaluate extrapolation assumptions.
Honda GS; Pearce RG; Pham LL; Setzer RW; Wetmore BA; Sipes NS; Gilbert J; Franz B; Thomas RS; Wambaugh JF
PLoS One; 2019; 14(5):e0217564. PubMed ID: 31136631
[TBL] [Abstract][Full Text] [Related]
27. Physiologically based toxicokinetics (PBTK) models for pharmaceuticals and personal care products in wild common carp (Cyprinus carpio).
Zhang S; Wang Z; Chen J
Chemosphere; 2019 Apr; 220():793-801. PubMed ID: 30612048
[TBL] [Abstract][Full Text] [Related]
28. Development of a preliminary physiologically based toxicokinetic (PBTK) model for 1,3-butadiene risk assessment.
Sweeney LM; Himmelstein MW; Gargas ML
Chem Biol Interact; 2001 Jun; 135-136():303-22. PubMed ID: 11397398
[TBL] [Abstract][Full Text] [Related]
29. The Application of a Physiologically Based Toxicokinetic Model in Health Risk Assessment.
Chen M; Du R; Zhang T; Li C; Bao W; Xin F; Hou S; Yang Q; Chen L; Wang Q; Zhu A
Toxics; 2023 Oct; 11(10):. PubMed ID: 37888724
[TBL] [Abstract][Full Text] [Related]
30. Toxicokinetics as a key to the integrated toxicity risk assessment based primarily on non-animal approaches.
Coecke S; Pelkonen O; Leite SB; Bernauer U; Bessems JG; Bois FY; Gundert-Remy U; Loizou G; Testai E; Zaldívar JM
Toxicol In Vitro; 2013 Aug; 27(5):1570-7. PubMed ID: 22771339
[TBL] [Abstract][Full Text] [Related]
31. Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment.
Dixit R; Riviere J; Krishnan K; Andersen ME
J Toxicol Environ Health B Crit Rev; 2003; 6(1):1-40. PubMed ID: 12587252
[TBL] [Abstract][Full Text] [Related]
32. Arsenic toxicokinetic modeling and risk analysis: Progress, needs and applications.
Kenyon EM
Toxicology; 2021 Jun; 457():152809. PubMed ID: 33965444
[TBL] [Abstract][Full Text] [Related]
33. The importance of inclusion of kinetic information in the extrapolation of high-to-low concentrations for human limit setting.
Geraets L; Zeilmaker MJ; Bos PMJ
Toxicol Lett; 2018 Jan; 282():81-92. PubMed ID: 29030269
[TBL] [Abstract][Full Text] [Related]
34. Advancing internal exposure and physiologically-based toxicokinetic modeling for 21st-century risk assessments.
Cohen Hubal EA; Wetmore BA; Wambaugh JF; El-Masri H; Sobus JR; Bahadori T
J Expo Sci Environ Epidemiol; 2019 Jan; 29(1):11-20. PubMed ID: 30116055
[TBL] [Abstract][Full Text] [Related]
35. Exploring the potential and challenges of developing physiologically-based toxicokinetic models to support human health risk assessment of microplastic and nanoplastic particles.
Chen CY; Lin Z
Environ Int; 2024 Apr; 186():108617. PubMed ID: 38599027
[TBL] [Abstract][Full Text] [Related]
36. A physiologically based toxicokinetic model for the zebrafish Danio rerio.
Péry AR; Devillers J; Brochot C; Mombelli E; Palluel O; Piccini B; Brion F; Beaudouin R
Environ Sci Technol; 2014; 48(1):781-90. PubMed ID: 24295030
[TBL] [Abstract][Full Text] [Related]
37. Physicologically Based Toxicokinetic Models of Tebuconazole and Application in Human Risk Assessment.
Jónsdóttir SÓ; Reffstrup TK; Petersen A; Nielsen E
Chem Res Toxicol; 2016 May; 29(5):715-34. PubMed ID: 26977527
[TBL] [Abstract][Full Text] [Related]
38. Development of physiologically based toxicokinetic models for 3-monochloropropane-1,2-diol and glycidol.
Jia W; Jiang J; Ke X; Zhang L; Li Y; Wan X; Jiao J; Zhang Y
Food Chem Toxicol; 2023 Feb; 172():113555. PubMed ID: 36493944
[TBL] [Abstract][Full Text] [Related]
39. A Novel Multispecies Toxicokinetic Modeling Approach in Support of Chemical Risk Assessment.
Mangold-Döring A; Grimard C; Green D; Petersen S; Nichols JW; Hogan N; Weber L; Hollert H; Hecker M; Brinkmann M
Environ Sci Technol; 2021 Jul; 55(13):9109-9118. PubMed ID: 34165962
[TBL] [Abstract][Full Text] [Related]
40. Understanding receptor-mediated effects in rainbow trout: in vitro-in vivo extrapolation using physiologically based toxicokinetic models.
Brinkmann M; Eichbaum K; Buchinger S; Reifferscheid G; Bui T; Schäffer A; Hollert H; Preuss TG
Environ Sci Technol; 2014 Mar; 48(6):3303-9. PubMed ID: 24548176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
